SS Innovations International (NASDAQ: SSII) announced it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards. The award recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. The company said the award reflects growing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also said approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. These numbers underscore the system's rapid adoption and versatility across surgical specialties.
The SSi Mantra system is designed to make robotic surgery more accessible and affordable, addressing a key barrier to adoption in many healthcare systems. By offering a cost-effective alternative to established competitors, SS Innovations aims to expand the benefits of minimally invasive surgery to a larger segment of the global population. The company's vision is particularly relevant for developing regions where surgical robotic systems have been historically out of reach due to high costs.
For industry leaders, the recognition signals that the surgical robotics landscape is becoming more competitive, with new entrants challenging incumbents on price and training support. The award may also accelerate SS Innovations' commercial expansion, as healthcare providers increasingly seek systems that combine advanced capabilities with lower total cost of ownership. The company's success in performing over 175 telesurgeries highlights its potential to enable remote surgical expertise, which could improve access to specialized care in underserved areas.
SS Innovations plans to expand the global presence of its surgical robotic solutions, building on regulatory approvals already secured in 14 countries. The company's product range includes the SSi Mantra system and the SSi Mudra suite of surgical instruments, which support various procedures including cardiac surgery. As an American company headquartered in India, SS Innovations is positioned to serve both developed and emerging markets, potentially reshaping the competitive dynamics of the surgical robotics industry.
For more information, visit the Company's website at ssinnovations.com. The full press release is available at https://ibn.fm/XWdRe.
